Astrana Health, Inc. (NASDAQ:ASTH) Stock Has Consensus Target Price of $49.88 According to Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has been given a consensus rating of “Moderate Buy” by the ten ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $49.88.

ASTH has been the topic of a number of research analyst reports. TD Cowen upped their target price on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. BTIG Research lifted their price target on Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Wall Street Zen downgraded Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Oppenheimer began coverage on Astrana Health in a research note on Tuesday, September 15th. They issued an “outperform” rating and a $53.00 price objective on the stock. Finally, Barclays raised their price objective on Astrana Health from $50.00 to $53.00 and gave the company an “overweight” rating in a research report on Friday, August 7th.

Astrana Health Price Performance

Shares of ASTH opened at $37.55 on Thursday. The company has a market cap of $2.09 billion, a price-to-earnings ratio of 45.79 and a beta of 1.03. Astrana Health has a 1-year low of $18.08 and a 1-year high of $51.60. The company’s fifty day simple moving average is $37.05 and its 200 day simple moving average is $37.06. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 1.05.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The firm had revenue of $972.52 million for the quarter, compared to analyst estimates of $985.62 million. During the same period in the prior year, the firm posted $0.19 earnings per share. The company’s quarterly revenue was up 48.5% compared to the same quarter last year. On average, research analysts forecast that Astrana Health will post 1.36 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of large investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC lifted its holdings in Astrana Health by 730.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 689 shares of the company’s stock valued at $25,000 after purchasing an additional 606 shares during the last quarter. Tidal Investments LLC acquired a new position in shares of Astrana Health in the second quarter valued at $974,000. Engineers Gate Manager LP acquired a new position in shares of Astrana Health in the second quarter valued at $989,000. Corient Private Wealth LP increased its holdings in shares of Astrana Health by 1.6% in the second quarter. Corient Private Wealth LP now owns 24,905 shares of the company’s stock valued at $1,156,000 after purchasing an additional 399 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Astrana Health in the second quarter valued at about $529,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.

Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements.